MaxCyte (MXCT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MaxCyte, Inc., a cell-engineering company specializing in platform technologies for cell-based therapies, will participate in the Craig-Hallum Capital Group Bioprocessing Conference virtually on September 19th. A replay of MaxCyte’s conference session will be accessible on their investor relations website. The company is known for its ExPERT platform, which supports the cell therapy market from research to commercialization.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.